pharmaphorum

NOVEMBER 11, 2020

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. With AI already the key engine for a growing list of consumer devices, the trend has created exciting opportunities for pharma and healthcare. “We have now entered a new phase of AI implementation where AI-based technology is expected to be foundational and not just a novel technology,” Abid Rahman, vice president, innovation,

Pharmaceutical Companies 139

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 139

Outsourcing Pharma

NOVEMBER 12, 2020

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

137

137

Druggist

NOVEMBER 13, 2020

Ibuprofen is a common medication used in the management of pain, fever, and to reduce inflammation. Alongside paracetamol (Calpol) it is one of the first medicines considered by parents when a child is ill. However, ibuprofen may not be recommended as the drug of choice in a particular group of children or to treat specific conditions. Today I answer the question: Can you use ibuprofen for chickenpox?

Hospitals 98

Hospitals 98

Pharma Times

NOVEMBER 9, 2020

Phase III study of vaccine candidate involved 43,538 participants

Vaccines 54

Vaccines 54

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

NOVEMBER 13, 2020

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. The pharma world is no exception, and this year both small and large players have made the transition – partly out of necessity – from a world that relied predominantly on the face-to-face side of doing business, into a new digital world.

Pharmaceutical Companies 124

Pharmaceutical Companies Pharmaceutical Companies 124

Outsourcing Pharma

NOVEMBER 12, 2020

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

98

98

Pharma Times

NOVEMBER 13, 2020

Agreement follows positive phase III data announcement

Vaccines 54

Vaccines 54

pharmaphorum

NOVEMBER 11, 2020

In the second positive piece of COVID-19 vaccine news in a week, Russia’s Sputnik V candidate has been shown to be 92% effective at the interim point of a 40,000-patient study. The preliminary assessment is based on 20 coronavirus cases split between the vaccinated and placebo arms of the study at 21 days, according to a press statement issued this morning by the Gamaleya Institute which developed the shot and the Russian Direct Investment Fund (RDIF).

Vaccines 116

Vaccines 116

Outsourcing Pharma

NOVEMBER 9, 2020

President-elect Joe Biden has launched a Transition COVID-19 Advisory Board to support the USâ COVID-19 response.

93

93

Pharma Marketing Network

NOVEMBER 13, 2020

On November 12, 2020, The Pharma CX Tech Summit held their third annual conference. The topics focused on the emerging technologies that pharma is implementing to enhance customer experiences for patients, payers, and HCPs. These technologies include AI/ML, voice & chat, connected devices, AR/VR, automation, personalization, and telehealth. . During the summit, speakers shared their thoughts and opinions on new technologies, how to prioritize customer experiences during COVID-19, and their

Communication 52

Communication 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 10, 2020

Akcea’s Waylivra approved via ultra-orphan pathway

52

52

pharmaphorum

NOVEMBER 13, 2020

Hungary is to order a consignment of Russia’s Sputnik V COVID-19 vaccine, as the country struggles to contain the infection rate. According to press reports , the decision puts Hungary on “collision course” with the EU, which has not approved the vaccine or plans to review it either. The European Medicines Agency has announced rolling reviews of vaccines from mainstream pharma companies including Pfizer/BioNTech and AstraZeneca, which allow regulators to review data in real time, allowing them t

Vaccines 115

Vaccines 115

Outsourcing Pharma

NOVEMBER 10, 2020

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

83

83

Pharma Marketing Network

NOVEMBER 12, 2020

Healthcare Internet Conference ( HCIC) | November 16-19, 2020 | VIRTUAL. Greystone.Net’s annual Healthcare Internet Conference (HCIC) is the premier conference for healthcare marketing, IT, web, data analytics, business development, public relations and communication leaders who are responsible for their organization’s public-facing websites, intranets, portals, social channels, mobile strategy and CRM strategies.

Communication 52

Communication 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

NOVEMBER 11, 2020

Contributing factors such as the excessive carbon dioxide in the atmosphere and burned fossil fuels wounds the earth at large. Highly dangerous pollutants from agricultural runoffs, industrial junks, and even pharmaceutical waste can decrease human life expectancy by three years. Pharmaceutical Pollution This type of pollution is practically a form of water pollution.

52

52

pharmaphorum

NOVEMBER 13, 2020

US data analysis company Palantir Technologies could be drafted in to manage the UK government’s troubled COVID-19 Test and Trace programme, according to press reports. Palantir has been linked with the project for several weeks and the Financial Times is the latest to suggest that the company could get involved with the troubled project. Palantir was founded in 2003 by a team including paypal co-founder Peter Thiel and the company’s billionaire CEO Alex Karp.

Documentation 112

Documentation 112

Outsourcing Pharma

NOVEMBER 10, 2020

Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.

Hospitals 78

Hospitals 78

Pharma Marketing Network

NOVEMBER 11, 2020

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. This event focused on the many different changes that are happening in pharma marketing due to COVID and what the industry’s future may look like.

Communication 52

Communication 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

NOVEMBER 12, 2020

Interim data analysis comes from phase III clinical trials in the Russian Federation

Vaccines 51

Vaccines 51

pharmaphorum

NOVEMBER 11, 2020

In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respiratory medicine. The post Health Innovators: David Van Sickle on digital innovation in respiratory medicine appeared first on.

111

111

Outsourcing Pharma

NOVEMBER 9, 2020

According to a survey by trial solutions company Greenphire, patient recruitment and enrollment levels have bounced back since the pandemic struck.

59

59

Med Ed 101

NOVEMBER 11, 2020

Irritable bowel syndrome can be very difficult to manage in some patients and once controlled, you can imagine that the patient wants nothing more than to keep their symptoms at bay. I’ve seen medications that exacerbate IBS-diarrhea used in clinical practice and really upset the balance of control. Here are a few of the more […]. The post Medications That Exacerbate IBS-Diarrhea appeared first on Med Ed 101.

40

40

Pharma Times

NOVEMBER 9, 2020

Industry bodies respond to Specialised Committee outcome

50

50

pharmaphorum

NOVEMBER 9, 2020

Novo Nordisk has agreed to buy Emisphere Technologies for $1.8 billion, as it continues its quest to develop diabetes medicines that can be taken as pills. Copenhagen-based Novo Nordisk already markets Rybelsus (semaglutide), a version of its GLP-1 class drug that can help to control blood sugar levels in patients with type 2 disease. But the company has tried and failed to produce insulin that can be taken orally – this proved unfeasible due to the high doses of the hormone that were needed for

111

111

Outsourcing Pharma

NOVEMBER 12, 2020

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

FDA 56

FDA 56

pharmaphorum

NOVEMBER 12, 2020

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be used to develop its endocannabinoid drugs for central nervous system disorders. The Basel-based biotech – which was incubated in Switzerland’s BaseLaunch accelerator – is concentrating on developing a new class of small-molecule drugs for anxiety, mood and stress-related disorders.

Compounding 106

Compounding 106

pharmaphorum

NOVEMBER 12, 2020

CatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy targeting Growth Differentiation Factor 15 (GDF-15). The round was led by Vesalius Biocapital III, with participation from Novartis Venture Fund (NVF), Wachstumsfonds Bayern, coparion and founding investors Forbion and BioGeneration Ventures.

Immunization 105

Immunization Compounding 105

pharmaphorum

NOVEMBER 12, 2020

The European Union has ordered 300 million doses of BioNTech/Pfizer’s COVID-19 vaccine following this week’s landmark announcement that it was effective in more than 90% of patients. The companies said deliveries of an initial order of 200 million vaccines will be subject to approval by European regulators and are expected to start by the end of this year.

Vaccines 105

Vaccines 105

pharmaphorum

NOVEMBER 13, 2020

Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option after NICE gave the nod to NHS funding of Roche’s Tecentriq and Avastin combination therapy. The decision by NICE comes shortly after Tecentriq (atezolizumab) and Avastin (bevacizumab) was approved by the European Commission as a first-line treatment for adults with advanced or inoperable HCC, becoming the first and only immunotherapy regimen approve

Documentation 105

Documentation 105

pharmaphorum

NOVEMBER 9, 2020

There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve on standard interventions, according to the Institute for Clinical and Economic Review. The US cost-effectiveness watchdog has concluded in an evidence report that none of three digital therapies under scrutiny – apps from Pear Therapeutics, Chess Health and DynamiCare Health – have data from a randomised clinical trial showing they can enhance long-term abstinence or retention rat

FDA 104

FDA 104

pharmaphorum

NOVEMBER 9, 2020

The FDA may have been minded to approve Biogen and Eisai’s Alzheimer’s candidate aducanumab, but its clinical advisors have little doubt that the evidence for the drug is lacking. The much-anticipated advisory committee meeting held on Friday to discuss the marketing application for aducanumab proved to be a fractious affair, with both the companies’ data – and some of the FDA’s interpretation of it – under fire by panellists.

FDA 98

FDA Documentation 98

pharmaphorum

NOVEMBER 9, 2020

As the death toll from COVID19 inexorably mounts, Pfizer and BioNTech have announced that their COVID-19 vaccine candidate is more than 90% effective at countering the disease in an interim analysis. The companies said they will be ready to file the vaccine with the FDA in the third week of November once they have enough safety data to meet the regulator’s requirements.

Vaccines 98

Vaccines Hospitals FDA 98

pharmaphorum

NOVEMBER 12, 2020

In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present. I’ve been an avid observer of pharma social media for some time and this is somewhat unusual. Not for the pharma employees to be proud of the work they do, but such a spontaneous and widespread demonstration of pride in our industry is not normally seen, though it is thoroughly deserved here.

Vaccines 87

Vaccines FDA 87